2023 Woman & Home Best Night Cream Award Winner.
An innovative, technology-infused moisturiser that helps the skin to cleverly adapt to micro-climatic changes throughout the day, leaving skin feeling strengthened and ultra-resilient from the elements. It delivers a continuous dose of moisture for maximum hydration while targeting the visible signs of ageing, for skin that looks radiant, rejuvenated and transformed.
- This clinically proven* formula features a Climatic Shock Adaptor that helps the skin feel comfortable in extreme temperature and humidity changes
- Creates an invisible veil on the skin to help protect the complexion against microdust and dulling atmospheric and indoor pollutants
- In just 28 days,* skin feels smooth as silk and the appearance of deep-set lines and wrinkles are dramatically reduced
*Independent clinical trials 2019. Results based on 31 people over four weeks.
What is it?
Reveal a complexion that is glowing with a renewed feeling of resilience and strength. The ultimate fusion of adaptogenic and line fighting technology, this velvety cream helps the skin adjust to micro-climatic changes throughout the day, leaving the skin feeling smooth and ultra-hydrated in all environments. Clinically proven,* the advanced moisturiser wraps the skin in a protective cocoon of 24-hour moisture while helping to protect from atmospheric pollution that can compromise the skin’s natural barrier. Designed to support thinning skin, it improves the feeling of elasticity while softening the look of deep-set lines, for a younger, firmer-looking complexion.
Why use it?
These extreme changes in temperature and humidity that can impact the skin, leading to dehydration, lines and loss of elasticity. This technology-infused moisturiser is clinically proven* to support the skin’s needs in different environments, leaving the skin feeling more resilient and strengthened. ULTRA SMART Aqua Shuttle Technology delivers a continuous infusion of moisture to the skin for prolonged, intense hydration.
*Independent clinical trials 2019. Results based on 31 people over four weeks.
